The mystery of what’s causing young people’s cancer leads to the gut

UC expert featured in Wall Street Journal article

The University of Cincinnati Cancer Center's Jordan Kharofa was featured in a Wall Street Journal article discussing the role of diet and the gut in rising levels of gastrointestinal (GI) cancers among young people.

GI cancer rates among people under 50 are increasing worldwide. Colorectal cancer is the leading cause of cancer death in the U.S. in men under 50 and second for women behind breast cancer. As these rates increase, more researchers including Kharofa have turned to the gut for answers.

“There’s an interplay most likely between the things we eat, the bacteria in the gut, and what those bacteria produce,” said Kharofa, MD, a Cancer Center physician researcher and associate professor and vice chair of education in the Department of Radiation Oncology in UC's College of Medicine.

Kharofa's research has found one species of bacteria in the gut that is associated with a sulfur microbial diet, or a diet that is both high in processed meats, low-calorie drinks and liquor and low in raw fruits, vegetables and legumes, is found in higher levels in young colorectal cancer patients.

Read more about Kharofa's research.

Read the Wall Street Journal article.

Featured photo at top of colorectal cancer cells courtesy of the National Cancer Institute.

Related Stories

2

Health care industry is hiring despite a job market that has cooled

April 16, 2026

The US labor market has cooled but the demand for health care workers, expecially skilled nurses, remains strong. Interviews with UC College of Nursing admininstrators Dr. Donna Green and Dr. Lindsay Davis were part of a WCPO segment on health care industry hiring.

3

AI advances in the liver disease field

April 15, 2026

MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.